Biotech stocks are risky, volatile, and potentially worth a fortune. But are they biblically sound?

Some evangelical investors are betting Christian-friendly stocks can outperform the market, and they’re leaning heavily on biotech to prove them right.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • ‘“That’s what we call inspiring transformation,” Netzly said.’

    Since scientists are overwhelmingly non-religious, imposing religion on biotechs will inspire an exodus or two and “Inspire” will be radioactive.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy